Related Experiment Video
Updated: Sep 1, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
The epidemiology and therapeutic options for the COVID-19
Jingwei Li1, Jun Shao1, Chengdi Wang1
1Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, Chengdu 610041, China.
Insights
This review summarizes the latest research on coronavirus disease 2019 (COVID-19), covering its virology, epidemiology, clinical features, and treatments. It also explores asymptomatic carriers to aid in combating the global pandemic.
Area of Science:
- * Infectious Diseases
- * Virology
- * Epidemiology
Background:
- * The emergence of coronavirus disease 2019 (COVID-19) represents a significant global health crisis.
- * COVID-19 is the third major coronavirus epidemic in the 21st century, following SARS and MERS.
- * The World Health Organization (WHO) has declared COVID-19 a global pandemic due to its widespread impact.
Purpose of the Study:
- * To provide a comprehensive overview of the current understanding of COVID-19.
- * To review advances in the virology, epidemiology, clinical characteristics, and therapeutic strategies for COVID-19.
- * To explore the role and implications of asymptomatic carriers in disease transmission.
Main Methods:
- * Literature review of recent scientific publications and research findings.
- * Synthesis of data on COVID-19 virology and epidemiology.
- * Analysis of clinical features, treatment options, and prevention strategies.
Main Results:
- * Detailed insights into the novel pneumonia virus causing COVID-19.
- * Epidemiological data highlighting the global spread and impact of the pandemic.
- * Summary of current therapeutic options and preventive measures, including the study of asymptomatic transmission.
Conclusions:
- * A thorough understanding of COVID-19's multifaceted aspects is crucial for effective pandemic control.
- * Continued research into pathophysiology, clinical management, and asymptomatic transmission is essential.
- * The findings support ongoing global efforts to combat the COVID-19 pandemic through informed strategies.
Abstract:
An outbreak of coronavirus disease 2019 (COVID-19), a disease caused by a novel pneumonia virus, has affected over 200 countries and regions worldwide. With the increasing number of patients and deaths, WHO have declared it as a global pandemic currently, indicating a third large-scale epidemic coronavirus has appeared since the emergence of severe acute respiratory syndrome coronavirus (SARS) and Middle-East respiratory syndrome (MERS) in the twenty-first century. Considering the great harm it has caused, researchers throughout the world have been chasing to exploit the pathophysiology, characteristics, and potential remedies for COVID-19 to better battle the outbreak. Therefore, the current study revisits advances of the virology, epidemiology, clinical features, therapeutic options, and prevention of COVID-19. The features of asymptomatic carriers are also been explored.
More Related Videos
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Microorganisms in Medicine and Therapeutics
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Myocarditis III: Medical Management
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

